As a member of protein tyrosine phosphatase (PTP), PTPRN is an autoantigen in the sera of insulin-dependent diabetes mellitus (IDDM) patients, making it a promising therapeutic target of autoimmunity in IDDM (Rabin et al., 1994; Solimena et al., 1996). The gene discussed is PTPRN; the disease is Autoimmunity.